– Interview with Robert Wechsler-Reya, Ph.D., Associate Professor of Pharmacology and Cancer Biology, Duke University Medical Center

Previous articleNeurologix Licenses to Aegera’ XIAP Gene for Use in Huntington’s
Next articleAcucela and Otsuka Ally to Advance Compounds for Treating Dry AMD and Dry Eye